Publication | Open Access

Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis

Tumor BiologyPreclinical Mouse ModelMalignant DiseasePeritoneal CarcinomatosisMedicinePathologyTumor TargetingCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentCancer Research213Bi-labelled Tumour-homing Peptides